David Katz to Aged, 80 and over
This is a "connection" page, showing publications David Katz has written about Aged, 80 and over.
Connection Strength
0.345
-
Katz DE, Leibner G, Kaufman N, Esayag Y, Brammli-Greenberg S, Rose AJ. Improving Discrimination in Predicting Level of Care Needed for Patients Admitted with Pneumonia. J Gen Intern Med. 2025 Sep; 40(13):3051-3057.
Score: 0.116
-
Ben-Chetrit E, Bnaya A, Barchad OW, Vedder K, Katz DE. Chloramphenicol treatment revisited - demographics, clinical characteristics, and outcomes of hospitalized patients. Eur J Clin Microbiol Infect Dis. 2024 Aug; 43(8):1667-1671.
Score: 0.109
-
Katz DE, Friedman ND, Ostrovski E, Ravid D, Amrami N, Avivi D, Mengesha B, Zaidenstein R, Lazarovitch T, Dadon M, Marchaim D. Diabetic foot infection in hospitalized adults. J Infect Chemother. 2016 Mar; 22(3):167-73.
Score: 0.061
-
Leibner G, Katz DE, Esayag Y, Kaufman N, Brammli-Greenberg S, Rose AJ. Incorporating clinical and demographic data into the Elixhauser Comorbidity Model: deriving and validating an enhanced model in a tertiary hospital's internal medicine department. BMC Health Serv Res. 2024 Dec 05; 24(1):1523.
Score: 0.028
-
Ben-Chetrit E, Assous MV, Wiener-Well Y, Katz DE, Kashat L, Zeevi DA, Hadelsberg UP, Gonen L, Margalit N, Shahar T. When a Root Is the Cause of Infection. World Neurosurg. 2020 12; 144:258-261.e1.
Score: 0.021
-
Rehm S, Campion M, Katz DE, Russo R, Boucher HW. Community-based outpatient parenteral antimicrobial therapy (CoPAT) for Staphylococcus aureus bacteraemia with or without infective endocarditis: analysis of the randomized trial comparing daptomycin with standard therapy. J Antimicrob Chemother. 2009 May; 63(5):1034-42.
Score: 0.009